Hörn, Helmut; Nink, Katrin; McGauran, Natalie; … - In: Health Policy 116 (2014) 2, pp. 147-153
Rising drug costs in Germany led to the Act on the Reform of the Market for Medicinal Products (AMNOG) in January 2011. For new drugs, pharmaceutical companies have to submit dossiers containing all available evidence to demonstrate an added benefit versus an appropriate comparator therapy. The...